Antisense oligonucleotides directed against the viral RNA polymerase gene enhance survival of mice infected with influenza A.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 10385324.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We have investigated the ability of antisense phosphorothioate oligonucleotides to enhance the survival of mice infected with influenza A virus. The oligonucleotides were complementary to sequences surrounding the translation initiation codons of the viral PB2 or PA genes (PB2-as or PA-as, respectively) of the influenza A virus RNA polymerases. Intravenous administration of PB2-as in a complex with a cationic liposome, Tfx-10, significantly prolonged the mean survival time in days and increased overall survival rates of mice infected with the influenza A virus. Liposomally encapsulated PB2-as inhibited viral growth in lung tissues and reduced pulmonary consolidations. Liposomally encapsulated PB2-as could be an effective therapeutic agent against influenza A virus.
Medical subject headings
- DNA-Directed RNA Polymerases
- Influenza A virus
- Oligonucleotides, Antisense
- Orthomyxoviridae Infections
- Thionucleotides